These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2965205)
41. Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion. Martinez de la Escalera G; Weiner RI Endocr Rev; 1992 May; 13(2):241-55. PubMed ID: 1618163 [TBL] [Abstract][Full Text] [Related]
42. Dopamine inhibits the release of immunoreactive beta-endorphin from rat hypothalamus in vitro. Vermes I; Tilders FJ; Stoof JC Brain Res; 1985 Feb; 326(1):41-6. PubMed ID: 3155984 [TBL] [Abstract][Full Text] [Related]
43. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion. Timmerman W; Poelman RT; Westerink BH; Schuiling GA Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275 [TBL] [Abstract][Full Text] [Related]
44. A screen for modulators reveals that orexin-A rapidly stimulates thyrotropin releasing hormone expression and release in hypothalamic cell culture. Cote-Vélez A; Martínez Báez A; Lezama L; Uribe RM; Joseph-Bravo P; Charli JL Neuropeptides; 2017 Apr; 62():11-20. PubMed ID: 28173961 [TBL] [Abstract][Full Text] [Related]
45. Attenuation of anterior pituitary phosphoinositide phosphorylase activity by the D2 dopamine receptor. Jarvis WD; Judd AM; MacLeod RM Endocrinology; 1988 Dec; 123(6):2793-9. PubMed ID: 2904359 [TBL] [Abstract][Full Text] [Related]
46. Dopamine inhibits thyrotropin-releasing hormone release from rat adrenal gland in vitro. Mitsuma T; Sun DH; Nogimori T; Chaya M; Ohtake K; Hirooka Y Horm Res; 1987; 25(4):223-7. PubMed ID: 3108135 [TBL] [Abstract][Full Text] [Related]
47. Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin. Junier MP; Dray F; Blair I; Capdevila J; Dishman E; Falck JR; Ojeda SR Endocrinology; 1990 Mar; 126(3):1534-40. PubMed ID: 1968382 [TBL] [Abstract][Full Text] [Related]
48. Testosterone regulates the secretion of thyrotrophin-releasing hormone (TRH) and TRH precursor in the rat hypothalamic-pituitary axis. Pekary AE; Knoble M; Garcia NH; Bhasin S; Hershman JM J Endocrinol; 1990 May; 125(2):263-70. PubMed ID: 2115563 [TBL] [Abstract][Full Text] [Related]
49. Dopaminergic neurones in the zona incerta exert a stimulatory control on gonadotrophin release via D1 dopamine receptors. James MD; MacKenzie FJ; Tuohy-Jones PA; Wilson CA Neuroendocrinology; 1987 May; 45(5):348-55. PubMed ID: 3035408 [TBL] [Abstract][Full Text] [Related]
50. The effect of blockade of dopamine receptors on the inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovariectomized rats. Gallo RV Endocrinology; 1978 Apr; 102(4):1026-35. PubMed ID: 744005 [TBL] [Abstract][Full Text] [Related]
52. Dopamine induces inhibitory effects on the circular muscle contractility of mouse distal colon via D1- and D2-like receptors. Auteri M; Zizzo MG; Amato A; Serio R J Physiol Biochem; 2016 Aug; 73(3):395-404. PubMed ID: 28600746 [TBL] [Abstract][Full Text] [Related]
53. Involvement of D1 dopamine receptors in the nicotine-induced neuro-endocrine effects and depletion of diencephalic catecholamine stores in the male rat. Andersson K; Fuxe K; Eneroth P; Härfstrand A; Agnati LF Neuroendocrinology; 1988 Aug; 48(2):188-200. PubMed ID: 2975769 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of hormonally induced inositol trisphosphate production in Transfected GH4 sup>C1 cells: A novel role for the D5 subtype of the dopamine receptor. White BH; Kimura K; Sidhu A Neuroendocrinology; 1999 Mar; 69(3):209-16. PubMed ID: 10087453 [TBL] [Abstract][Full Text] [Related]
55. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
56. Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal dopamine D2 receptors via the indirect striatal output pathway? Biggs CS; Fowler LJ; Whitton PS; Starr MS Brain Res; 1997 Apr; 753(1):163-75. PubMed ID: 9125444 [TBL] [Abstract][Full Text] [Related]
57. D2-dopamine receptor-mediated inhibition of intracellular Ca2+ mobilization and release of acetylcholine from guinea-pig neostriatal slices. Fujiwara H; Kato N; Shuntoh H; Tanaka C Br J Pharmacol; 1987 Jun; 91(2):287-97. PubMed ID: 2886167 [TBL] [Abstract][Full Text] [Related]
58. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Dreher JK; Jackson DM Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062 [TBL] [Abstract][Full Text] [Related]
59. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
60. Thyrotrophin-releasing hormone-induced growth hormone secretion in domestic fowl: concomitant stimulation of dopamine turnover in the medial basal hypothalamus. Harvey S; Lea RW J Endocrinol; 1993 Aug; 138(2):225-32. PubMed ID: 8228731 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]